Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes
Özet
Background: Aromatase inhibitors (AI) have been introduced to reduce estrogen exposure in women with estrogen-sensitive cancer undergoing ovarian stimulation for oocyte/embryo cryopreservation. There have been questions regarding whether the addition of A
Bağlantı
https://doi.org/10.1177/1933719117728800http://dspace.yeniyuzyil.edu.tr:8080/xmlui/handle/20.500.12629/2191
Koleksiyonlar
DSpace@İYYU by Istanbul Yeni Yüzyil University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..
